J J Dalal
Overview
Explore the profile of J J Dalal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guha S, Harikrishnan S, Ray S, Sethi R, Ramakrishnan S, Banerjee S, et al.
Indian Heart J
. 2018 Dec;
70(6):952-953.
PMID: 30580876
No abstract available.
2.
Guha S, Harikrishnan S, Ray S, Sethi R, Ramakrishnan S, Banerjee S, et al.
Indian Heart J
. 2018 Aug;
70 Suppl 1:S1-S72.
PMID: 30122238
No abstract available.
3.
Dalal J, Amin P, Ansari A, Bhave A, Bhagwat R, Challani A, et al.
J Assoc Physicians India
. 2016 Sep;
63(12):41-50.
PMID: 27666903
Process: A working group of 15 experts in the management of acute PE (cardiologists, pulmonologist, haematologist, emergency specialist and intensivists). This consensus statement makes recommendations for diagnosis and management for...
4.
Dalal J, Alexander T, Banerjee P, Dayasagar V, lyengar S, Kerkar P, et al.
J Assoc Physicians India
. 2015 Apr;
62(6):473-83.
PMID: 25856911
Unlabelled: In India, the prevalence of ST elevation myocardial infarction (STEMI) is rising exponentially leading to cardiovascular morbidity and mortality. Despite advancement in reperfusion therapy (pharmacologic and interventional), the overall...
5.
Ashavaid T, Shalia K, Nair K, Dalal J
Indian J Clin Biochem
. 2012 Oct;
15(Suppl 1):1-10.
PMID: 23105263
Coronary constriction, proliferation of smooth muscle cells and arrhythmia are involved in the pathophysiology of coronary heart disease and its complications such as myocardial infarction and sudden death. All these...
6.
Dalal J, Kasliwal R, Dutta A, Sawhney J, Iyengar S, Dani S, et al.
Indian Heart J
. 2012 Oct;
64(5):503-7.
PMID: 23102390
Introduction: Sudden cardiac death (SCD) is the most lethal manifestation of heart disease. In an Indian study the SCDs contribute about 10% of the total mortality and SCD post ST...
7.
Tomlinson B, Dalal J, Huang J, Low L, Park C, Rahman A, et al.
Curr Med Res Opin
. 2011 Mar;
27(5):1021-33.
PMID: 21410302
Following publication of the National Institute of Clinical Excellence (NICE) Guidelines in 2006, the use of β-blockers as first-line therapy in hypertension has been somewhat controversial. However, a recent reappraisal...
8.
Vranckx P, Serruys P, Gambhir S, Sousa E, Abizaid A, Lemos P, et al.
EuroIntervention
. 2009 Sep;
2(3):310-7.
PMID: 19755306
Background: SIMPLE II was a multi-centre, prospective registry study aimed at investigating the safety and efficacy of the Infinnium (Sahajanand Medical Technologies Pvt. Ltd, India) paclitaxel-eluting stent for the treatment...
9.
Nair K, Shalia K, Ashavaid T, Dalal J
J Clin Lab Anal
. 2003 Aug;
17(5):141-6.
PMID: 12938141
Gene encoding components of the renin angiotensin system (RAS) have been implicated with the increased risk of cardiovascular disease (CVD). Two variants of the angiotensinogen (AGT) gene, M235T and T174M,...
10.
Nair K, Nair S, Ashavaid T, Dalal J, Eghlim F
J Assoc Physicians India
. 2002 Aug;
50 Suppl:9-15.
PMID: 12186157
Objective: The screening and therapeutic guidelines for the management of lipid abnormalities are reasonably well established. However, other risk factors like hyperhomocysteinemia (HCA) and single nucleotide polymorphisms involving the angiotensin...